Spots Global Cancer Trial Database for Evaluation of Pancreatic Duct Stenting in Patients With Pancreatic Pseudocysts.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of Pancreatic Duct Stenting in Patients With Pancreatic Pseudocysts.
Official Title: Randomized Multicenter Study on Pancreatic Duct Stenting in Disrupted or Obstructed Ducts in Context With Endoscopic Treatment of Pancreatic Pseudocysts.
Study ID: NCT01276002
Conditions
Interventions
Study Description
Brief Summary: The disruption of the pancreatic duct seems to be a major cause pseudocyst formation and persistence in patients suffering from acute/chronic pancreatitis. No prospective randomized studies have been conducted on the influence of pancreatic duct stenting for the patients' benefits and recurrence rates. The aim fo this study is therefore to evaluate prospectively in a randomized, controlled fashion in patients wit pancreatic pseudocysts, wether pancreatic duct stenting of a disrupted pancreatic duct is beneficial in terms of quicker clinical recovery and avoidance of recurrence of pancreatic pseudocysts.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Interdisciplinary Endoscopy, University hospital Schleswig-Holstein, Campus Kiel, Kiel, , Germany
Contact Details
Name: Mark Ellrichmann, MD
Affiliation: Interdisciplinary Endoscopy, University hospital Schleswig-Holstein, Campus Kiel, Germany
Role: PRINCIPAL_INVESTIGATOR
Name: Annette Fritscher-Ravens, MD, PhD
Affiliation: Interdisciplinary Endoscopy, University hospital Schleswig-Holstein, Campus Kiel, Germany
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
